Nexus - 0301 - New Times Magazine-pages

Page Content (OCR)

Despite aspartame's dangerous side­ effects, the US FDA continues to approve it while food and drug manufacturers find more ways to use it. Are the facts being deliberately concealed from consumers? Part 2 @1995 by Mark D. Gold 35 In.man 5t, Cambridge, MA 02139, USA
Phone: (617) 497 7843
E-maH: mgold@tiac.net
Web page; http;Jlwww.tiac.nel/mgoIW users/health.html Extracted with permission from Blazing Tattles VolA, Nos. 4, 5, 6. April-June 1995 DECEMBER 1995 -JANUARY 1996 In the mid-1970s it was discovered that the manufacturer of asptrtame falsified stud­ ies in several ways. One of the techniques used was to cut tuJflours out of test ani­ mals and put the animals back in the study. Another technique used to falsify the studies was to list animals that had actually died as surviving the study. Thus, the data on brain tumours was likely worse than discussed above. In addition, Raymond Schroeder, a former employee of the manufacturer of aspaname, told the FDA on 13th July 1977 that the particles of DKP were so large that the rats could discriminate between the DKP and their normal diet" It is interesting to note that the incidence of brain tumours in persons over 65 years of age has increased 67 per cent between thi:: years 1973 and 1990. Brain tumours in all age­ groups have jumped 10 per cent. The greatest increase has come during the years 1985 to 1987." In his book, Aspartame (NutraSweet): Is it Safe?, H. J. Roberts, M.D. gives evi­ dence that aspartaroe can cause a particularly dangerous form of cancer: primary lym­ phoma of the brain. Diabetes The American Diabetes Association (ADA) is actually recommending this chemical poison to persons with diabetes. According to research conducted by H. 1. Roberts (a dia­ betes specialist, member of the ADA and an authority on artificial sweeteners), aspartame; I) leads to the precipitation of clinical diabetes; 2) causes poorer diabetic control in diabetics on insulin or oral drugs; 3) leads to the aggravation of diabetic complications such as retinopathy, cataracts, neu­ ropathy and gastroparesis; 4) causes convulsions. In a statement concerning the use of products containing aspartame by persons with dia­ betes and hypoglycaemia, Roberts says: UnfortUllately, many patients in my practice, and others seen in consultation, developed, serious metabolic, neurologic and other complications that could be specifically attrib­ uted to using aspartame products. This was evidenced by the loss ofdiabetic control, the intensification of hypoglycaemia, the occurrence ofpresumed 'insulin reactions' (including convulsions) that proved to be aspartame reactions, and the precipitation, aggravation or simulation of diabetic compli-. cations (especially impaired vision and neuropathy) while using these products. Dramatic improvement of such features [occurs} after avoiding aspartame, and the prompt predictable recurrence of these probletns [result} when the patient resumed aspartame products, knowingly or inadvertently. Roberts goes on to say; Iregretthefailureofotherphysicians andtheAmerican DiabetesAssociation tosound appropriate warnings to patients and consumers based on these repeated findings which have been described in my corporate-neutral studies and publications. Russell Blaylock stated that excitotoxins such as those found in aspartame can precipi­ tate diabetes in persons who are genetically susceptible to the disease.'" Emotional Disorders A double-blind study of the effects of aspartame on persons with mood disorders was recently conducted by Dr Ralph G. Walton. Since the study wasn't funded/controlled by the makers of aspartame, The NutraSweet Company refused to sell him the aspartame. Walton was forced to obtain and certify it from an outside source. NEXUS. 31